Does CETUXIMAB Cause Hypomagnesaemia? 255 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Hypomagnesaemia have been filed in association with CETUXIMAB (ERBITUX). This represents 1.8% of all adverse event reports for CETUXIMAB.
255
Reports of Hypomagnesaemia with CETUXIMAB
1.8%
of all CETUXIMAB reports
22
Deaths
106
Hospitalizations
How Dangerous Is Hypomagnesaemia From CETUXIMAB?
Of the 255 reports, 22 (8.6%) resulted in death, 106 (41.6%) required hospitalization, and 11 (4.3%) were considered life-threatening.
Is Hypomagnesaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CETUXIMAB. However, 255 reports have been filed with the FAERS database.
What Other Side Effects Does CETUXIMAB Cause?
Off label use (1,549)
Rash (883)
Diarrhoea (874)
Neutropenia (744)
Nausea (663)
Malignant neoplasm progression (662)
Dyspnoea (542)
Decreased appetite (541)
Vomiting (533)
Death (518)
What Other Drugs Cause Hypomagnesaemia?
OMEPRAZOLE (1,766)
PANTOPRAZOLE (1,246)
PANITUMUMAB (611)
ESOMEPRAZOLE (591)
CARBOPLATIN (586)
LANSOPRAZOLE (504)
FUROSEMIDE (501)
FLUOROURACIL (477)
METFORMIN (415)
CISPLATIN (395)
Which CETUXIMAB Alternatives Have Lower Hypomagnesaemia Risk?
CETUXIMAB vs CETYLPYRIDINIUM
CETUXIMAB vs CEVIMELINE
CETUXIMAB vs CHAMPIX
CETUXIMAB vs CHANTIX
CETUXIMAB vs CHENODIOL